4//SEC Filing
TULLIS DICKERSON CAPITAL FOCUS III, L.P. 4
Accession 0001209191-20-021042
CIK 0001274737other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 7:49 PM ET
Size
11.5 KB
Accession
0001209191-20-021042
Insider Transaction Report
Form 4
EXAGEN INC.XGN
Transactions
- Other
Common Stock
2020-03-20−164,420→ 1,625,165 total(indirect: See footnote)
Footnotes (2)
- [F1]Tullis and Tullis Growth, respectively, (as each is defined in Footnote (2) below) distributed in the aggregate 164,420 shares of Common Stock of Exagen Inc. to their respective non-affiliate limited partners on a pro rata basis, for no consideration.
- [F2]The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth Fund, L.P. ("Tullis Growth") and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001144359
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 7:49 PM ET
- Size
- 11.5 KB